Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

The world was unprepared for coronavirus disease 2019 (COVID-19) and remains ill-
equipped for future pandemics. While unprecedented strides have been made developing …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a range of
symptoms in infected individuals, from mild respiratory illness to acute respiratory distress …

With the continual evolution of new strains of severe acute respiratory syndrome coronavirus-
2 (SARS-CoV-2) that are more virulent, transmissible, and able to evade current vaccines …

Severe COVID-19 is associated with epithelial and endothelial barrier dysfunction within the
lung as well as in distal organs. While it is appreciated that an exaggerated inflammatory …

There is a critical need for physiologically relevant, robust, and ready-to-use in vitro cellular
assay platforms to rapidly model the infectivity of emerging viruses and develop new …

Bats are potential natural reservoirs for emerging viruses, causing deadly human diseases,
such as COVID-19, MERS, SARS, Nipah, Hendra, and Ebola infections. The fundamental …

SUMMARY SARS-CoV-2 can cause a range of symptoms in infected individuals, from mild
respiratory illness to acute respiratory distress syndrome. A systematic understanding of the …

Abstract SARS coronavirus 2 (SARS-CoV-2) has caused an ongoing global pandemic with
significant mortality and morbidity. At this time, the only FDA-approved therapeutic for COVID …

The deadliest recent pandemic outbreak of COVID-19 disease has severely damaged the
socio-economic health of the people globally. Due to unavailability of any effective vaccine …